These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 38230665)
1. Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence. Dorado P; M Peñas-Lledó E Pharmacogenomics; 2024 Jan; 25(2):55-58. PubMed ID: 38230665 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update. Zhu H; Deng FY; Mo XB; Qiu YH; Lei SF Pharmacogenomics; 2014 Mar; 15(4):551-66. PubMed ID: 24624921 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of therapies in rheumatoid arthritis. Ranganathan P Drugs Today (Barc); 2005 Dec; 41(12):799-814. PubMed ID: 16474855 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacogenomics of antirheumatic drugs and personalized medicine for rheumatoid arthritis]. Taniguchi A; Urano W; Tanaka E; Kamatani N Nihon Rinsho; 2007 Feb; 65(2):371-9. PubMed ID: 17302286 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics in rheumatoid arthritis. Ranganathan P Methods Mol Biol; 2008; 448():413-35. PubMed ID: 18370240 [TBL] [Abstract][Full Text] [Related]
6. Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis? Ranganathan P; Eisen S; Yokoyama WM; McLeod HL Ann Rheum Dis; 2003 Jan; 62(1):4-9. PubMed ID: 12480661 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics in rheumatoid arthritis. Sen D; Paul JR; Ranganathan P Methods Mol Biol; 2014; 1175():625-60. PubMed ID: 25150878 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics in rheumatoid arthritis: how close are we to the clinic? Ponchel F; Burska AN; Vital EM Pharmacogenomics; 2014 Jul; 15(10):1275-9. PubMed ID: 25155929 [No Abstract] [Full Text] [Related]
9. Pharmacogenomics of methotrexate in rheumatoid arthritis: does race make a difference? Dervieux T J Rheumatol; 2008 Apr; 35(4):550-2. PubMed ID: 18398948 [No Abstract] [Full Text] [Related]
10. Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort. Owen SA; Lunt M; Hider SL; Bruce IN; Barton A; Thomson W Arthritis Rheum; 2010 Dec; 62(12):3827-9. PubMed ID: 20848569 [No Abstract] [Full Text] [Related]
11. Validation of the associations between single nucleotide polymorphisms or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a proposal for prospective pharmacogenomic study in clinical practice. Taniguchi A; Urano W; Tanaka E; Furihata S; Kamitsuji S; Inoue E; Yamanaka M; Yamanaka H; Kamatani N Pharmacogenet Genomics; 2007 Jun; 17(6):383-90. PubMed ID: 17502830 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine. Umićević Mirkov M; Coenen MJ Pharmacogenomics; 2013 Mar; 14(4):425-44. PubMed ID: 23438889 [TBL] [Abstract][Full Text] [Related]
14. An update on pharmacogenomics in rheumatoid arthritis with a focus on TNF-blocking agents. Ranganathan P Curr Opin Mol Ther; 2008 Dec; 10(6):562-7. PubMed ID: 19051134 [TBL] [Abstract][Full Text] [Related]